glp 1 for binge eating The rapid rise of GLP-1 receptor agonists presents a complex dilemma clinicians managing patients with disorders. While these medications show potential in reducing eating behaviors by targeting brain reward GLP-1 receptor agonists: A novel

10.3390/nu15030739

Bidzinska B, Petraglia F, Angioni S, et al

Several factors may contribute to dizziness in patients taking GLP-1 medications: Hypoglycaemia (low blood glucose) particularly when GLP-1 agonists are used alongside other glucose-lowering medications such as sulphonylureas or insulin Dehydration resulting from reduced fluid intake due to decreased appetite or from gastrointestinal side effects such as nausea, vomiting, or diarrhoea Orthostatic hypotension a drop in blood pressure upon standing, which may occur due to volume depletion or rapid weight loss Reduced caloric intake significant appetite suppression may lead to inadequate nutrition, potentially causing weakness and dizziness The frequency and severity of dizziness vary between individuals and specific GLP-1 products

Are you vegan or avoid capsules and gummies made with animal products

Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry